Perrigo to switch to NYSE from Nasdaq

The pharmaceutical company will transfer its listing to the New York Stock Exchange on June 6.

Perrigo Company (Nasdaq:PRGO; TASE:PRGO) today announced that it will transfer its listing from Nasdaq to the New York Stock Exchange on June 6. It will keep its ticker "PRGO". To mark the occasion, company representatives will ring the opening bell.

Last year, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) transferred from Nasdaq to the NYSE.

Perrigo chairman and CEO Joseph Papa said, "We are looking forward to listing on the NYSE as this change will provide increased visibility and enhanced services that will benefit our shareholders. We remain committed to making quality healthcare more affordable for our customers and patients and continuing to increase shareholder value."

"Perrigo and the NYSE are a perfect fit, and we're thrilled to welcome one of the world's leading healthcare suppliers to the world's leading equities market," said NYSE Euronext CEO Duncan Niederauer. "Perrigo was founded more than a century ago seeking to best serve and empower customers, continually innovate, and deliver quality products. That vision, which remains in place today, set the stage for the company's growth and global leadership."

Published by Globes [online], Israel business news - www.globes-online.com - on May 23, 2013

© Copyright of Globes Publisher Itonut (1983) Ltd. 2013

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018